State Street
KMTS icon

State Street’s Kestra Medical Technologies KMTS Stock Holding History

State Street’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22M Buy
779,200
+31,497
+4% +$803K ﹤0.01% 2290
2026
Q2 		$19M Buy
747,703
+76,591
+11% +$1.6M ﹤0.01% 2413
2026
Q1 		$13.4M Buy
671,112
+234,965
+54% +$5.54M ﹤0.01% 2452
2025
Q4 		$11.6M Buy
436,147
+160,022
+58% +$4.12M ﹤0.01% 2574
2025
Q3 		$6.56M Buy
276,125
+142,691
+107% +$2.55M ﹤0.01% 2873
2025
Q2 		$2.21M Buy
+133,434
New +$2.91M ﹤0.01% 3276

Other funds holding KMTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return

State Street's KMTS Position: Q3 2026 in Review

State Street increased its Kestra Medical Technologies (KMTS) stake by 4.2% in Q3 2026, buying an estimated $803K and bringing the position to 779,200 shares worth $22M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

State Street first reported a position in KMTS in Q2 2025 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • State Street held 779,200 shares of Kestra Medical Technologies worth $22M as of Q3 2026.
  • State Street bought 31,497 Kestra Medical Technologies shares in Q3 2026, an estimated $803K.
  • Kestra Medical Technologies made up ﹤0.01% of State Street's portfolio in Q3 2026, its #2290 holding.
  • State Street first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.